TNF and psoriasis: Since prominent epidermal hyperplasia is thought to result from the interaction between keratinocytes and a complex cytokine network due to abnormal T-cell regulation, many effective therapies targeting TNF-α, IL-23, or IL-17 have been developed and used to treat patients with psoriasis [42].